Investigation of serum IL-12, IL-16, and IL-17A as diagnostic biomarkers in children with cow’s milk protein allergy
Main Article Content
Keywords
allergy, cow’s milk protein allergy, inflammation
Abstract
Background: Cow’s milk protein allergy (CMPA) is an abnormal immune response caused by milk proteins and is most common in infancy and early childhood. Statistics revealed up to 7.5% of children suffered from milk allergy. Its clinical symptoms were characterized by diversity, non-specificity, and can affect multiple systems, including the digestive tract, skin, and respiratory tract. In this study, we aimed to investigate the effects of IL-12, IL-16, and IL-17A on diagnosing and monitoring CMPA in children for clinical treatment.
Methods: A total of 158 infants with CMPA and 89 healthy babies were recruited and evaluated. Demographic and clinical information of all participants were recorded. An extensive analysis of inflammatory cytokine levels, including IL-12, IL-16, and IL-17A, was performed in blood samples from 247 infants younger than 9 months. Meanwhile, the serological specificity immunoglobulin E (sIgE) levels were evaluated. In addition, the area under the curve (AUC) values of IL-12, IL-16, and IL-17A in differentiating CMP from healthy babies were measured by receiver operating characteristic analysis. Finally, the correlation between sIgE and IL-12, IL-16, and IL-17A levels were detected using Spearman correlation analysis.
Results: Compared with healthy control, infants who developed CMPA had decreased IL-12, increased IL-16, and IL-17A. Moreover, a significant correlation between serum IL-12, IL-16, IL-17A and sIgE levels was observed in the CMPA group. In addition, AUC values of IL-12, IL-16, and IL-17A in discriminating CMPA from healthy infants were 0.8425, 0.9196, and 0.8813, respectively. Finally, IL-12 was increased while IL-16 and IL-17A levels were decreased in the CMPA group after three months of milk avoidance treatment.
Conclusions: We found that IL-12, IL-16, and IL-17A levels in children with CMPA were associated with SCORAD scores, sIgE levels, and disease severity, functioning as valuable disease-monitor markers in CMPA.
References
2. Nowak-Węgrzyn A, Katz Y, Mehr SS, Koletzko S. Non-IgE-mediated gastrointestinal food allergy. J Allergy Clin Immunol. 2015;135(5):1114–24. 10.1016/j.jaci.2015.03.025
3. Burks AW, Sampson HA, Plaut M, Lack G, Ardis CA. Treatment for food allergy. J Allergy Clin Immunol. 2018;141(1):1–9. 10.1016/j.jaci.2017.11.004
4. Xu GF, Snetselaar LG, Jing J, Liu BY, Strathearn L, Bao W. Association of food allergy and other allergic conditions with autism spectrum disorder in children. JAMA Netw Open. 2018;1(2):e180279. 10.1001/jamanetworkopen.2018.0279
5. Wang XY, Zhuang Y, Ma TT, Zhang B, Wang XY. Prevalence of self-reported food allergy in six regions of Inner Mongolia, Northern China: a population-based survey. Med Sci Monit. 2018;24:1902–11. 10.12659/msm.908365
6. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol. 2010;125(2):S116–25. 10.1016/j.jaci.2009.08.028
7. Gupta RS, Warren CM, Smith BM, Jiang J, Blumenstock JA, Daviset MM, et al. Prevalence and severity of food allergies among US adults. JAMA Netw Open. 2019;2(1):e185630. 10.1001/jamanetworkopen.2018.5630
8. Comberiati P, Costagliola G, D’Elios S, Peroni D. Prevention of food allergy: the significance of early introduction. Medicine. 2019;55(7):323. 10.3390/medicina55070323
9. Guadamuro L, Diaz M, Jiménez S, Molinos-Norniella C, Pérez-Solis D, Rodríguez JM, et al. Fecal changes following introduction of milk in infants with outgrowing non-IgE CMPA are influenced by previous consumption of the probiotic LGG. Front Immunol. 2019;10:1819. 10.3389/fimmu.2019.01819
10. Navarrete-Rodríguez EM, Ríos-Villalobos LA, Alcocer-Arreguín CR, Del-Rio-Navarro BE, Del Rio-Chivardi JM, Saucedo-Ramírezet OJ, et al. Cross-over clinical trial for evaluating the safety of camel’s milk intake in patients who are allergic to cow’s milk protein. Allergol Immunopathol. 2018;46(2):149–54. 10.1016/j.aller.2017.06.005
11. Ho MHK, Lee SL, Wong WHS, Ip P, Lau YL. Prevalence of self-reported food allergy in Hong Kong children and teens--a population survey. Asian Pac J Allergy Immunol. 2012;30(4):275–84.
12. Schichter-Konfino V, Almog M, Bamberger E, Berkowitz D, Kessel A. The significance of allergic contact urticaria to milk in children with cow’s milk allergy. Pediatr Allergy Immunol. 2015;26(3):218–22. 10.1111/pai.12375
13. Teymourpour P, Pourpak Z, Fazlollahi MR, Barzegar S, Shokouhi, Rosita Akramian, et al. Cow’s milk anaphylaxis in children first report of Iranian food allergy registry. Iran J Allergy Asthma Immunol. 2012;11(1):29–36. 10.1186/2045-7022-1-S1-P47
14. Franco JM, Pinheiro APSG, Vieira SCF, Barreto IDC, Gurgel RQ, Coccoet RR, et al. Accuracy of serum IgE concentrations and papule diameter in the diagnosis of cow’s milk allergy. J Pediatr. 2018;94(3):279–85. 10.1016/j.jped.2017.06.022
15. Sommanus S, Kerddonfak S, Kamchaisatian W, Vilaiyuk S, Sasisakulporn C, Teawsomboonkit W, et al. Cow’s milk protein allergy: immunological response in children with cow’s milk protein tolerance. Asian Pac J Allergy Immunol. 2014;32(2):171–7. 10.12932/AP0319.32.2.2013
16. Norgaard A, Skov PS, Bindslev-Jensen C. Egg and milk allergy in adults: comparison between fresh foods and commercial allergen extracts in skin prick test and histamine release from basophils. Clin Exp Allergy. 1992;22(10):940–7. 10.1111/j.1365-2222.1992.tb02068.x
17. Majamaa H, Moisio P, Holm K, Kautiainen H, Turjanmaa K. Cow’s milk allergy: diagnostic accuracy of skin prick and patch tests and specific IgE. Allergy. 1999;54(4):346–51. 10.1034/j.1398-9995.1999.00834.x
18. Iacono G, Cavataio F, Montalto G, Florena A, Tumminello M, Soresi M, et al. Intolerance of cow’s milk and chronic constipation in children. N Engl J Med. 1998;339(16):1100–4. 10.1056/NEJM199810153391602
19. Manti S, Lougaris V, Cuppari C, Tardino L, Dipasquale V, Arrigo T, et al. Breastfeeding and IL-10 levels in children affected by cow’s milk protein allergy: a restrospective study. Immunobiology. 2017;222(2):358–62. 10.1016/j.imbio.2016.09.003
20. Toro-Monjaraz EM, Fonseca-Camarillo G, Zárate-Mondragón F, Montijo-Barrios E, Cadena-León J, Avelar-Rodríguez D, et al. Differential cytokine expression in the duodenum and rectum of children with non-immunoglobulin e-mediated cow’s milk protein allergy. Dig Dis Sci. 2021;66(11):3769–75. 10.1007/s10620-020-06743-z
21. Luyt D, Ball H, Makwana N, Green MR, Bravin K, Nasser SM, et al. BSACI guideline for the diagnosis and management of cow’s milk allergy. Clin Exp Allergy. 2014;44(5):642–72. 10.1111/cea.12302
22. Bedoret D, Singh AK, Shaw V, Hoyte EG, Hamilton R, DeKruyff RH, et al. Changes in antigen-specific T-cell number and function during oral desensitization in cow’s milk allergy enabled with omalizumab. Mucosal Immunol. 2012;5(3):267–76. 10.1038/mi.2012.5
23. Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow’s milk allergy. J Allergy Clin Immunol. 2004;114(1):131–6. 10.1016/j.jaci.2004.03.036
24. Canani RB, Paparo L, Nocerino R, Cosenza L, Pezzella V, Di Costanzo M, et al. Differences in DNA methylation profile of Th1 and Th2 cytokine genes are associated with tolerance acquisition in children with IgE-mediated cow’s milk allergy. Clin Epigenetics. 2015;7(1):38. 10.1186/s13148-015-0070-8
25. Fonseca-Camarillo G, Furuzawa-Carballeda J, Iturriaga-Goyon E, Yamamoto-Furusho JK. Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease. Biomed Res Int. 2018;2018:5140691. 10.1155/2018/5140691
26. Teng DK, Liu Y, Lv YF, Wang L, Zhange W, Wang J-P, et al. Elevated interleukin-35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection. Int Immunopharmacol. 2019;70:252–9. 10.1016/j.intimp.2019.02.048
27. Libetta C, Rampino T, Canton AD. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis. 2001;38(2):286–95. 10.1053/ajkd.2001.26092
28. Kirmaz C, Bayrak P, Yilmaz O, Yuksel H. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study. Eur Cytokine Netw. 2005;16(2):128–34.
29. Tagoma A, Haller-Kikkatalo K, Roos K, Oras A, Kirss A, Ilonenet J, et al. Interleukin-7, T helper 1, and regulatory T-cell activity-related cytokines are increased during the second trimester of healthy pregnancy compared to non-pregnant women. Am J Reprod Immunol. 2019;82(6):e13188. 10.1111/aji.13188
30. Glatt S, Baeten D, Baker T, Griffiths M, Ionescu L, Lawsonet ADG, et al. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Ann Rheum Dis. 2018;77(4):523–32. 10.1136/annrheumdis-2017-212127
31. Yawalkar N, Brand CU, Braathen LR. Interleukin-12 expression in human afferent lymph derived from the induction phase of allergic contact dermatitis. Br J Dermatol. 1998;138(2):297–300. 10.1046/j.1365-2133.1998.02078.x
32. Todberg T, Zachariae C, Krustrup D, Skov L. The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis. Int J Dermatol. 2019;58(3):e58–e61. 10.1111/ijd.14347
33. Testa B, Mesolella C, Mosti MR, Mesolella M, Testa D, Motta G. Changes in serum interferon-gamma, interleukin-4, and interleukin-12 cytokine levels in anti-histamine type 2-treated allergic rhinitis patients. Laryngoscope. 2001;111(2):236–9. 10.1097/00005537-200102000-00009
34. Pullerits T, Lindén A, Malmhäll C, Lötvall J. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Allergy. 2001;56(9):871–7. 10.1111/j.1398-9995.2001.00916.x
35. Abbasi R, Zomorodian K, Shahrabadi ZZ, Saadat F, Nabavizadeh SH, Esmaeilzadeh H, et al. IL-25 and IL-33 serum levels are not associated with the type of allergen causing allergic rhinitis. Iran J Immunol. 2019;16(4):321–6. 10.22034/IJI.2019.80283
36. Tazaki T, Minoguchi K, Yokoe T, Oda N, Hashimoto T, Tanaka A, et al. Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor beta2 chain expression in patients with allergic asthma. Cell Immunol. 2004;228(1):20–6. 10.1016/j.cellimm.2004.03.008
37. Afifi SS, ElArab AE, Mostafa SY. Interleukin 16 (IL-16) in asthma and allergic rhinitis. A comparison between upper and lower airways. Egypt J Immunol. 2004;11(2):31–36.
38. Graser A, Ekici AB, Sopel N, Melichar VO, Zimmermann T, Papadopoulos NG, et al. Rhinovirus inhibits IL-17A and the downstream immune responses in allergic asthma. Mucosal Immunol. 2016;9(5):1183–92. 10.1038/mi.2015.130
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.